Saturday, 24 July 2010

Novaminsulfon




Novaminsulfon may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Novaminsulfon



Metamizole

Metamizole sodium anhydrous (a derivative of Metamizole) is reported as an ingredient of Novaminsulfon in the following countries:


  • Germany

Metamizole sodium monohydrate (a derivative of Metamizole) is reported as an ingredient of Novaminsulfon in the following countries:


  • Germany

International Drug Name Search

Tuesday, 20 July 2010

Amiodarona Clorhidrato




Amiodarona Clorhidrato may be available in the countries listed below.


Ingredient matches for Amiodarona Clorhidrato



Amiodarone

Amiodarone hydrochloride (a derivative of Amiodarone) is reported as an ingredient of Amiodarona Clorhidrato in the following countries:


  • Chile

  • Peru

International Drug Name Search

Monday, 19 July 2010

Terbasmin




Terbasmin may be available in the countries listed below.


Ingredient matches for Terbasmin



Terbutaline

Terbutaline sulfate (a derivative of Terbutaline) is reported as an ingredient of Terbasmin in the following countries:


  • Spain

International Drug Name Search

Friday, 16 July 2010

Vitamin B2




In the US, Vitamin B2 (riboflavin systemic) is a member of the drug class vitamins and is used to treat Dietary Supplementation, Headache, Migraine Prevention and Vitamin/Mineral Supplementation and Deficiency.

US matches:

  • Vitamin B2

Ingredient matches for Vitamin B2



Riboflavin

Riboflavin is reported as an ingredient of Vitamin B2 in the following countries:


  • Latvia

Riboflavin phosphate sodium salt (a derivative of Riboflavin) is reported as an ingredient of Vitamin B2 in the following countries:


  • Japan

International Drug Name Search

Thursday, 15 July 2010

Penicillinum procainicum L




Penicillinum procainicum L may be available in the countries listed below.


Ingredient matches for Penicillinum procainicum L



Benzylpenicillin

Benzylpenicillin procaine (a derivative of Benzylpenicillin) is reported as an ingredient of Penicillinum procainicum L in the following countries:


  • Poland

International Drug Name Search

Saturday, 10 July 2010

Rilutek


Rilutek is a brand name of riluzole, approved by the FDA in the following formulation(s):


RILUTEK (riluzole - tablet; oral)



  • Manufacturer: SANOFI AVENTIS US

    Approval date: December 12, 1995

    Strength(s): 50MG [RLD][AB]

Has a generic version of Rilutek been approved?


A generic version of Rilutek has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Rilutek and have been approved by the FDA:


riluzole tablet; oral



  • Manufacturer: IMPAX LABS

    Approval date: January 29, 2003

    Strength(s): 50MG [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Rilutek. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Use of 2-amino-6-(trifluoromethoxy)benzothiazole for obtaining a medicament for the treatment of amyotrophic lateral sclerosis
    Patent 5,527,814
    Issued: June 18, 1996
    Inventor(s): Louvel; Erik
    Assignee(s): Rhone Poulenc Rorer S.A.
    Use of 2-amino-6-(trifluoromethoxy)benzothiazole, or a salt of this compound with a pharmaceutically acceptable acid, for obtaining a medicament intended for the treatment of motor neuron diseases, in particular amyotrophic lateral sclerosis, and especially amyotrophic lateral sclerosis with early bulbar involvement or the bulbar form of the disease.
    Patent expiration dates:

    • June 18, 2013



See also...

  • Rilutek Consumer Information (Wolters Kluwer)
  • Rilutek Consumer Information (Cerner Multum)
  • Rilutek Advanced Consumer Information (Micromedex)
  • Rilutek AHFS DI Monographs (ASHP)
  • Riluzole Consumer Information (Wolters Kluwer)
  • Riluzole Consumer Information (Cerner Multum)
  • Riluzole Advanced Consumer Information (Micromedex)
  • Riluzole AHFS DI Monographs (ASHP)